ArticleAnnals of medicine2025
Prognostic value of preablative stimulated thyroglobulin and its decline after
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- LLM-Enhanced Multimodal Fusion of SPECT Radiomics and Clinical Data for Predicting 131I Therapeutic Response in Differentiated Thyroid Cancer.Molecular imaging and biology · 2026Article
- Dynamic phenotyping of radioiodine-refractory differentiated thyroid cancer: thyroglobulin trajectories, dual-modal imaging, and genotype-defined treatment resistance.Frontiers in endocrinology · 2026Article
- Predicting unfavorable response to initial radioactive iodine therapy in differentiated thyroid cancer: an explainable machine learning and survival analysis approach.Frontiers in endocrinology · 2026Article
- Clinical and metabolic factors associated with response to postoperative radioactive iodine therapy in Chinese obese patients with papillary thyroid carcinoma.Frontiers in endocrinology · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe incidence of differentiated thyroid cancer (DTC) has been increasing, highlighting the need for reliable predictors of treatment response. This study aimed to assess the prognostic value of stimulated thyroglobulin (sTg) levels before and after the first
methodsSixty patients were classified into excellent response (ER) and non-excellent response (NER) groups based on a comprehensive evaluation of imaging findings, sTg, suppressed Tg and other parameters. Clinical and pathological variables were analyzed using univariate and multivariate logistic regression. Receiver operating characteristic (ROC) curve analysis was used to determine optimal cut-off values for pre-
resultsBoth pre-
conclusionLower pre-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.